EUVIMEDEUVIMED entdecken
Leitlinie

Effect of the 2022 AAP Guideline for Managing Hyperbilirubinemia in the Newborn

Ramya Balasubramanian, Khang Nguyen, Shanice Wells, David L Schutzman

American Journal of Perinatology · 2026-04 · 43 (05) · 643-647

DOI: 10.1055/a-2663-5668 ↗

Kurz gefasst

Leitlinie in der Zeitschrift American Journal of Perinatology, online erschienen am 07.08.2025. Verfasst von Ramya Balasubramanian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Jefferson Einstein Philadelphia Hospital, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Phototherapy, Hyperbilirubinemia, Neonatal, Practice Guidelines as Topic, Bilirubin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The American Academy of Pediatrics (AAP) provides guidelines for managing hyperbilirubinemia in term newborns ≥35 weeks' gestation to prevent kernicterus. In 2022, the AAP revised these guidelines by raising thresholds for serum bilirubin testing and phototherapy. This study compares newborn outcomes before and after implementing the 2022 guidelines. A retrospective chart review of 2,087 newborns, with 1,058 in the “before” group, using the 2004 guidelines, and 1,029 in the “after” group, using the 2022 guidelines. Data collected included demographics, number of heel sticks for serum bilirubin, incidence of phototherapy, and incidence of readmission for hyperbilirubinemia. There was a 64% reduction in serum bilirubin draws, a 51% decrease in phototherapy sessions, and a 35% reduction in readmissions for phototherapy in the “after” group. The 2022 AAP guidelines streamlined the management of hyperbilirubinemia, leading to fewer interventions without affecting patient safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhototherapyHyperbilirubinemia, NeonatalPractice Guidelines as TopicBilirubinHumansInfant, NewbornRetrospective StudiesFemaleMalePatient ReadmissionUnited StatesKernicterusSocieties, Medical

Substanzen

Bilirubin

Autor:innen und Institutionen

  • Department of Pediatrics, Jefferson Einstein Philadelphia Hospital, Philadelphia, Pennsylvania.
  • Division of Newborn Medicine, Maria Fareri Children's Hospital, Westchester, New York.

Zitieren

APA

Balasubramanian, R., Nguyen, K., Wells, S., & Schutzman, D. L. (2026). Effect of the 2022 AAP Guideline for Managing Hyperbilirubinemia in the Newborn. American Journal of Perinatology, 43(05), 643-647. https://doi.org/10.1055/a-2663-5668

Vancouver

Balasubramanian R, Nguyen K, Wells S, Schutzman DL. Effect of the 2022 AAP Guideline for Managing Hyperbilirubinemia in the Newborn. American Journal of Perinatology. 2026;43(05):643-647. doi:10.1055/a-2663-5668

BibTeX
@article{Balasubramanian2026,
  author = {Balasubramanian, Ramya and Nguyen, Khang and Wells, Shanice and Schutzman, David L},
  title = {Effect of the 2022 AAP Guideline for Managing Hyperbilirubinemia in the Newborn},
  journal = {American Journal of Perinatology},
  year = {2026},
  volume = {43},
  number = {05},
  pages = {643--647},
  doi = {10.1055/a-2663-5668}
}
Kostenlos starten →